BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/24/2021 2:07:00 AM | Browse: 776 | Download: 2146
 |
Received |
|
2021-02-01 15:08 |
 |
Peer-Review Started |
|
2021-02-01 15:34 |
 |
First Decision by Editorial Office Director |
|
2021-03-07 06:31 |
 |
Return for Revision |
|
2021-03-07 06:31 |
 |
Revised |
|
2021-04-06 08:38 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2021-05-18 09:05 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2021-05-18 22:40 |
 |
Articles in Press |
|
2021-05-18 22:40 |
 |
Edit the Manuscript by Language Editor |
|
2021-07-02 09:29 |
 |
Typeset the Manuscript |
|
2021-08-16 01:52 |
 |
Publish the Manuscript Online |
|
2021-08-24 02:07 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Case Report |
| Article Title |
Aspirin-induced long-term tumor remission in hepatocellular carcinoma with adenomatous polyposis coli stopgain mutation: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qu Lin, Ming-Jun Bai, Hao-Fan Wang, Xiang-Yuan Wu, Ming-Sheng Huang and Xing Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Guangzhou Science and Technology Project |
201904010461 |
| Major Talents Project of Guangdong Province |
2019TQ05Y266 |
|
| Corresponding Author |
Xing Li, MD, Professor, Department of Medical Oncology and Guangdong Key laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, No. 600 Tianhe Road, Guangzhou 510630, Guangdong Province, China. lixing9@mail.sysu.edu.cn |
| Key Words |
Hepatocellular carcinoma; Mutation; Wnt pathway; Aspirin; Adenomatous polyposis coli; Case report |
| Core Tip |
Hepatocellular carcinoma (HCC) is a highly heterogeneous disease. Due to the differences in etiology and ethnicities, the driving genes in HCC are likely to be different globally. Adenomatous polyposis coli (APC) mutations are critical in a fraction of HCC patients, as APC mutations might trigger HCC by activating the Wnt pathway. The effects of this mutation could be consistently suppressed by aspirin. Thus, APC mutation-triggered HCC might be a new subgroup of chronic hepatitis B virus infection-related HCC. Wnt pathway inhibition could be an effective remedy for this subgroup of patients. |
| Publish Date |
2021-08-24 02:07 |
| Citation |
Lin Q, Bai MJ, Wang HF, Wu XY, Huang MS, Li X. Aspirin-induced long-term tumor remission in hepatocellular carcinoma with adenomatous polyposis coli stopgain mutation: A case report. World J Clin Cases 2021; 9(24): 7189-7195 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i24/7189.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i24.7189 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.